SEOUL– Cellivery Therapeutics Inc.on Thursday announced that it will sell stocks to raise 15.5 billion won(US$13.2 million). The proceeds from the stock offering will be used primarily to finance its operations.
According to a regulatory filing, the company will issue 281,303 preferred shares at a price of 55,100 won per share. The stocks will be sold to the investors that the firm designated.
Source: Yonhap News Agency